Evidence map›Paper›PMID 24616771›Full record

ArticleEndocrinology, diabetes & metabolism case reports2013

Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism.

Suresh Chandran, Fabian Yap Kok Peng, Victor Samuel Rajadurai, Yap Te Lu, Kenneth T E Chang, S E Flanagan, S Ellard, Khalid Hussain

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Congenital Hyperinsulinism With Paternally InheritedJournal of the ASEAN Federation of Endocrine Societies · 2026
    Article
  2. Article
  3. Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.Therapeutic advances in endocrinology and metabolism · 2020
    Review
  4. Article
  5. Review
  6. Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.Circulation. Genomic and precision medicine · 2018
    Article
  7. Article
  8. A Case Series: Congenital Hyperinsulinism.International journal of endocrinology and metabolism · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Suresh ChandranDepartment of Neonatology KK Women's and Children's Hospital 100 Bukit Timah Road, Singapore, 229899 Singapore.
Fabian Yap Kok PengDepartment of Paediatric Endocrinology KK Women's and Children's Hospital 100 Bukit Timah Road, Singapore, 229899 Singapore.
Victor Samuel RajaduraiDepartment of Neonatology KK Women's and Children's Hospital 100 Bukit Timah Road, Singapore, 229899 Singapore.
Yap Te LuDepartment of Paediatric Surgery KK Women's and Children's Hospital 100 Bukit Timah Road, Singapore, 229899 Singapore.
Kenneth T E ChangDepartment of Children's Pathology KK Women's and Children's Hospital 100 Bukit Timah Road, Singapore, 229899 Singapore.
S E FlanaganInstitute of Biomedical and Clinical Science, University of Exeter Medical School Exeter, EX2 5DW UK.
S EllardInstitute of Biomedical and Clinical Science, University of Exeter Medical School Exeter, EX2 5DW UK.
Khalid HussainDepartment of Paediatric Endocrinology Great Ormond Street Hospital for Children NHS Trust London, WC1N 3JH UK.
KK Women's and Children's Hospital · SGUniversity of Exeter · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital hyperinsulinism (CHI) is a rare genetic disorder characterised by inappropriate insulin secretion in the face of severe hypoglycaemia. There are two histological subtypes of CHI namely diffuse and focal. Diffuse CHI is most common due to recessive mutations in ABCC8/KCNJ11 (which encode the SUR/KIR6.2 components of the pancreatic β-cell KATP channel) whereas focal CHI is due to a paternally inherited ABCC8/KCNJ11 mutation and somatic loss of heterozygosity for the 11p allele inside the focal lesion. Fluorine-18-l-dihydroxyphenylalanine positron emission tomography/computed tomography ((18)F-DOPA-PET/CT) is used in the pre-operative localisation of focal lesions prior to surgery. Diffuse CHI if medically unresponsive will require a near total pancreatectomy whereas focal CHI will only require a limited lesionectomy, thus curing the patient from the hypoglycaemia.

aimsTo report the first case of genetically confirmed CHI in Singapore from a heterozygous paternally inherited ABCC8 mutation. METHODS/

resultsA term male infant presented with severe hyperinsulinaemic hypoglycaemia (HH) after birth and failed medical treatment with diazoxide and octreotide. Genetic testing (paternally inherited mutation in ABCC8/p.D1472N) suggested focal disease, but due to the unavailability of (18)F-DOPA-PET/CT to confirm focal disease, a partial pancreatectomy was performed. Interestingly, histology of the resected pancreatic tissue showed changes typical of diffuse disease.

conclusionHeterozygous paternally inherited ABCC8/KCNJ11 mutations can lead to diffuse or focal CHI. LEARNING POINTS: HH is a cause of severe hypoglycaemia in the newborn period.Paternal mutations in ABCC8/KCNJ11 can lead to diffuse or focal disease.(18)F-DOPA-PET/CT scan is the current imaging of choice for localising focal lesions.Gallium-68 tetra-aza-cyclododecane-N N'N″N-‴-tetra-acetate octreotate PET scan is not a useful imaging tool for localising focal lesions.The molecular mechanism by which a heterozygous ABCC8 mutation leads to diffuse disease is currently unclear.Focal lesions are curable by lesionectomy and so genetic studies in patients with HH must be followed by imaging using (18)F-DOPA-PET/CT scan.

Identifiers

PMID24616771
PMCPMC3922076
OpenAlexW1976748108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.